Jazz Pharmaceuticals
JAZZ
#1899
Rank
ยฃ7.73 B
Marketcap
ยฃ127.29
Share price
1.67%
Change (1 day)
32.48%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -ยฃ0.51 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are ยฃ4.15 Billion. In 2024 the company made an earning of ยฃ0.35 Billion, an increase over its 2023 earnings that were of ยฃ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.51 Billion-243.94%
2024 ยฃ0.35 B57.87%
2023 ยฃ0.22 B-179.92%
2022 -ยฃ0.28 Billion230.37%
2021 -ยฃ84.64 Million-141.02%
2020 ยฃ0.20 B-39.45%
2019 ยฃ0.34 B-14.2%
2018 ยฃ0.39 B20.03%
2017 ยฃ0.33 B-17.15%
2016 ยฃ0.39 B22.14%
2015 ยฃ0.32 B187.64%
2014 ยฃ0.11 B-50.79%
2013 ยฃ0.23 B73.63%
2012 ยฃ0.13 B41.69%
2011 ยฃ93.89 M116.61%
2010 ยฃ43.34 M262.77%
2009 ยฃ11.94 M-111.33%
2008 -ยฃ0.11 Billion1.31%
2007 -ยฃ0.11 Billion77.8%
2006 -ยฃ58.55 Million36.59%
2005 -ยฃ42.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Endo International
ENDPQ
-ยฃ1.8 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
ยฃ1.57 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.31 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel